Biofortuna Ltd appoints new chairman to lead next phase of growth
Ian has spent his business career in life sciences. He was founder and CEO of Biotrace International plc, a leading provider of rapid microbial testing systems and reagents, which was sold to 3M for $100M. Ian is currently non-executive chairman of Celsis Group Ltd and Cyprotex PLC, both Harwood Private Equity investments, a company for which Ian acts as an operational advisor. Ian has served on the boards of various public and private companies in strategic consultancy and business development capacities, including Evans Analytical Group, MyCelx Technologies Corporation and AOI Medical Inc.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.